Langer Medical Announces Platinum Sponsorship of Eurocrine, the European Registry for Endocrine Surgery
Advancing surgical outcomes through data
(PresseBox) (Waldkirch, 29.01.2025) Langer Medical, the renowned medical technology company based in Waldkirch, Germany, and part of the Brainlab Companies, announces Platinum Sponsorship of Eurocrine, beginning in 2025. This strategic partnership underscores the company’s ongoing commitment to advancing the field of endocrine surgery through innovation and expertise.About Eurocrine and its Mission
Eurocrine, the leading European registry for endocrine surgery, aims to enhance the quality and safety of surgeries involving endocrine glands such as the thyroid, parathyroid, adrenal glands, and pancreas. By systematically collecting and analyzing data, Eurocrine seeks to reduce postoperative complications and enhance patient outcomes. The registry serves as a valuable data source for research, contributing to the development of new treatments and the refinement of existing techniques. Surgeons and clinics can compare their performance with peers, identifying areas for improvement. Additionally, the data gathered supports the education and training of surgeons, promoting the dissemination of best practices and continuous improvement in surgical practices.
Langer Medical Commitment to Innovation and Patient Care
For nearly 30 years, Langer Medical has stood at the forefront of innovation in thyroid surgery. As subsidiary of Brainlab, a leading digital medical technology, Langer Medical leverages cutting-edge neuromonitoring solutions to contribute to a holistic 360° patient journey.
Intraoperative neuromonitoring (IONM) plays a critical role in thyroid surgery by providing real-time feedback on the functional integrity of the recurrent laryngeal nerve, significantly reducing the risk of nerve damage. This is particularly important given the complexity and delicacy of thyroid surgeries. By using IONM, surgeons can identify and preserve the nerve, thereby minimizing complications such as vocal cord paralysis, which can profoundly impact a patient's quality of life. The company’s advanced neuromonitoring technology exemplifies their unwavering commitment to patient safety and precision in endocrine surgery.
In modern digital surgery, the intelligent processing of patient data is crucial and together, Langer Medical and Eurocrine are dedicated to sustainably improving patient outcomes on a daily basis.
Looking Ahead
Scott-Coombes, Consultant Surgeon at the University Hospital of Wales in Cardiff represented Eurocrine at the contract signing and expanded on the collaboration. "We are thrilled to welcome Langer Medical as a Platinum Sponsor," said Scott-Coombes, "their support will be instrumental in advancing our mission to improve endocrine surgical practices across Europe." By partnering with Eurocrine, Langer Medical reaffirms its dedication to excellence in endocrine surgery and its commitment to supporting initiatives that drive forward the quality of surgical care. This sponsorship will enable Eurocrine to expand its reach and impact, ultimately benefiting patients and healthcare providers across Europe.